Retraction Note: The traditional tibetan medicine Yukyung Karne exhibits a potent anti-metastatic activity by inhibiting the epithelial to mesenchymal transition and cell migration
BMC Complementary Medicine and Therapies volume 23, Article number: 88 (2023)
Retraction Note: BMC Complement Med Ther 15, 182 (2015)
The Editor has retracted this article. After publication, concerns were raised regarding similar western blot control images in this article and the authors’ previous publication . The authors explained that the data in the two articles originated from the same experiments. Further checks by the Publisher identified the use of the SKOV6 cell line, which is reported to be contaminated with HeLa cells, making it an unsuitable model for ovarian cancer. This undermines the conclusion that Yukyung Karne could be used in the management of ovarian cancer metastasis. Due to the cell line issue, the Editor no longer has confidence in the conclusions of this article.
None of the authors agree to this retraction.
Choedon T, Dolma D, Mathan G, et al. Molecular insights into the anti-cancer properties of traditional tibetan medicine Yukyung Karne. BMC Complement Altern Med. 2014;14:380. https://doi.org/10.1186/1472-6882-14-380.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12906-015-0707-3.
About this article
Cite this article
Choedon, T., Mathan, G. & Kumar, V. Retraction Note: The traditional tibetan medicine Yukyung Karne exhibits a potent anti-metastatic activity by inhibiting the epithelial to mesenchymal transition and cell migration. BMC Complement Med Ther 23, 88 (2023). https://doi.org/10.1186/s12906-023-03918-9